Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Enteropathy-Associated T-Cell Lymphoma (Phase 1)
Hodgkin Disease (Phase 1)
Immune System Diseases (Phase 1/Phase 2)
Immunoproliferative Disorders (Phase 1/Phase 2)
Leukemia (Phase 1/Phase 2)
Leukemia-Lymphoma, Adult T-Cell (Phase 1)
Lymphatic Diseases (Phase 1/Phase 2)
Lymphoma (Phase 1/Phase 2)
Lymphoma, Extranodal NK-T-Cell (Phase 1)
Lymphoma, Large B-Cell, Diffuse (Phase 1)
Lymphoma, Large-Cell, Anaplastic (Phase 1)
Lymphoma, Non-Hodgkin (Phase 1/Phase 2)
Lymphoma, T-Cell (Phase 1)
Lymphoma, T-Cell, Cutaneous (Phase 1)
Lymphoma, T-Cell, Peripheral (Phase 2)
Lymphomatoid Papulosis (Phase 1)
Lymphoproliferative Disorders (Phase 1/Phase 2)
Mycosis Fungoides (Phase 1)
Neoplasms (Phase 1/Phase 2)
Neoplasms by Histologic Type (Phase 1/Phase 2)
Sezary Syndrome (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
